Skip to main content

MoneyWorks4Me

Biofil Chem & Pharma - Quaterly Results

12 Nov 2021 Evaluate
The sales declined to Rs. 137.38 millions for the September 2021 quarter as compared to Rs. 160.19 millions during the corresponding quarter last year.A big loss of -77.00% reported for the quarter ended September 2021 to Rs. 2.13  millions from Rs. 9.26 millions.The company reported a degrowth in operating Profit to 4.04 millions from 10.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 137.38 160.19 -14.24 191.07 183.20 4.30 357.50 296.90 20.41
Other Income 0.31 1.46 -78.77 0.52 7.82 -93.35 8.00 1.72 365.12
PBIDT 4.04 10.55 -61.71 7.57 13.97 -45.81 23.99 19.95 20.25
Interest 0.10 0.20 -50.00 0.19 0.45 -57.78 0.68 1.22 -44.26
PBDT 3.94 10.35 -61.93 7.38 13.52 -45.41 23.31 18.73 24.45
Depreciation 1.03 1.09 -5.50 2.06 2.11 -2.37 4.12 4.08 0.98
PBT 2.91 9.26 -68.57 5.32 11.41 -53.37 19.19 14.65 30.99
TAX 0.78 0.00 0.00 1.45 0.00 0.00 6.78 2.57 163.81
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 3.50 0.00 0.00
PAT 2.13 9.26 -77.00 3.87 11.41 -66.08 12.41 12.08 2.73
Equity 162.74 162.74 0.00 162.74 162.74 0.00 162.74 162.74 0.00
PBIDTM(%) 2.94 6.59 -55.35 3.96 7.63 -48.04 6.71 6.72 -0.13
Peers
Company Name CMP
Redington 356.35
Adani Enterprises 2731.05
Amrapali Industries 34.31
Maxgrow India 175.85
Rashi Peripheral 864.95
View more..